Latest filing published 17 Dec 2019 for Spark Therapeutics, Inc., €1.3M.
Federico Mingozzi discloses dealings in Spark Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 26 June 2018 to 17 December 2019, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 17 December 2019, reports a transaction of €1.3M in Spark Therapeutics, Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations